Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05390541 · ClinicalTrials.gov registry record · NA
Increasing HIV/STI Home Testing Via a Digital Intervention Among Black Women
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05390541: Clinical Trial NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT05390541 is a NA study that was terminated before completion, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05390541, a NA study, was terminated before completion, sponsored by Johns Hopkins Bloomberg School of Public Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The proposed intervention is a web-based intervention guided by theoretical components to increase HIV home testing among Black women at risk for HIV and sexually transmitted infections (STIs) in a HIV hotspot in the South. The intervention will promote using the home test, linkage to care, and linkage to pre-exposure prophylaxis (PrEP) evaluation. The intervention has the potential to be implemented on a large scale and tailored based on location and population to increase testing, treatment, and PrEP adoption.
Primary Outcome
Self-report of use of HIV test within 4 days of receiving the test.
Interventions
- OTHER Educational Control
- BEHAVIORAL Empowered to Test Yourself
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
Why NCT05390541 stopped before completion
NCT05390541 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Educational Control is the first listed.
NCT05390541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05390541 about?
NCT05390541 is a clinical study titled "Increasing HIV/STI Home Testing Via a Digital Intervention Among Black Women". The proposed intervention is a web-based intervention guided by theoretical components to increase HIV home testing among Black women at risk for HIV and sexually transmitted infections (STIs) in a HIV hotspot in the South. The intervention will promote using the home test, linkage to care, and link...
What is the current status of trial NCT05390541?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2022-02-02. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT05390541?
The interventions under investigation include: Educational Control (OTHER), Empowered to Test Yourself (BEHAVIORAL).
Who is sponsoring clinical trial NCT05390541?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05390541's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI